Karunadileong 50 Units (Calidino genase)

Adult dose

Administer 30-150 I.U. orally per day in 3 divided doses. Adjust the dose appropriately according to age and symptoms.

This medication should not be used in patients with bleeding, such as immediately after a cerebral hemorrhage. Also, this drug contains lactose and should not be administered to patients with genetic metabolic disorders such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. When using this medication, hypersensitivity reactions such as skin rash or itching may occur, and if such symptoms appear, use should be stopped immediately. Sometimes symptoms of palpitations may appear, so caution is needed. Gastrointestinal symptoms may include stomach discomfort, nausea, vomiting, decreased appetite, upper abdominal pain, diarrhea, or constipation. Additionally, feelings of warmth may be felt, or rarely, symptoms such as headache, heaviness of the head, drowsiness, or fatigue may appear. In particular, older individuals may have weakened physiological functions, so careful management, such as adjusting the dosage when using this medication, is necessary.

• rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a sealed container to prevent air from entering, preferably at room temperature between 1 degree and 30 degrees. Storing it this way helps to maintain its effectiveness.

Appearance

White round enteric-coated film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle